Related Experiment Video
Updated: Jun 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Current guidelines for the management of asthma in young children
1Allergy Diagnostic & Clinical Research Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
Insights
Diagnosing and managing childhood asthma is complex due to varied wheezing symptoms. This review compares global guidelines to help clinicians manage young children with wheezy illnesses, aiding treatment decisions.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Clinical Guidelines
Background:
- Managing wheezing illnesses in young children presents diagnostic challenges due to diverse phenotypes and etiologies.
- Asthma diagnosis in early childhood is often difficult, requiring careful consideration of various clinical presentations.
Purpose of the Study:
- To review and compare recent global guidelines for diagnosing and managing asthma in young children.
- To provide clinicians with approaches for diagnosing asthma and selecting appropriate treatments based on individual patient factors.
Main Methods:
- A review of four major global guidelines published since 2007 concerning wheezy illnesses in young children.
- Analysis of guideline recommendations regarding diagnostic criteria, risk factors, age of presentation, treatment response, and safety.
Main Results:
- Guidelines offer useful information but differ in disease classification and treatment protocols.
- Diagnosis of asthma may be retrospective in some cases; effective initial treatment guidelines exist.
- Consistent review of ongoing pharmacological treatment is crucial as many infants with wheezing achieve spontaneous remission.
Conclusions:
- Recent global guidelines provide valuable frameworks for managing young children with wheezy illnesses.
- Personalized treatment decisions, considering risk factors and treatment response, are essential.
- Future biomarkers of airway inflammation may improve the timing of initiating and continuing pharmacological interventions.
Abstract:
The diagnosis and management of asthma in young children is difficult, since there are many different wheezy phenotypes with varying underlying aetiologies and outcomes. This review discusses the different approaches to managing young children with wheezy illnesses presented in recently published global guidelines. Four major guidelines published since 2007 are considered. Helpful approaches are presented to assist the clinician to decide whether a clinical diagnosis of asthma can, or should be made in a young child with a recurrent wheezy illness and which treatments would be appropriate, dependent on risk factors, age of presentation, response to initial treatment and safety considerations. Each of the guidelines provide useful information for clinicians assessing young children with recurrent wheezy illnesses. There are differences in classification of the disease and treatment protocols. Although a firm diagnosis of asthma may only be made retrospectively in some cases and there are several effective guidelines to initiating treatment. Consistent review of the need for ongoing treatment with a particular pharmacological modality is essential, since many children with recurrent wheezing in infancy go into spontaneous remission. It is probable that newer biomarkers of airway inflammation will assist the clinician as to when to initiate and when to continue pharmacological treatment in the future.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma III: Clinical Manifestations
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
